Abstract:Introduction Inflammasomes are cytosolic multi-component signaling platforms critical to the innate immune response to infectious diseases and the dysregulation of their activation can lead to the development of neurodegeneration and cancer. Objectives We aim through this review to ass a possible interplay between dysregulation of inflammasome activation, development of chronic inflammatory disease and enhancement of behavioral abnormalities. Methods We comprehensively review the scientific literature using Pubmed database and other search platforms such as Google scholar to assess the role and the actors of chronic activation of inflammasome signaling complexes to establish a potential association between dysregulation of inflammasome activation, chronic inflammatory disease and enhancement of behavioral abnormalities. Results Our bibliographic review revealed that dysregulation of the inflammasome is associated with the onset and progression of several autoinflammatory and autoimmune diseases, including cryopyrin-associated periodic fever syndrome, familial Mediterranean fever, rheumatoid arthritis, and systemic lupus erythematosus. These multimeric complexes form in response to molecular patterns unique to pathogens and cellular damage, triggering a cascade of downstream responses, including the induction of pyroptotic cell death and release of proinflammatory cytokines. Some inflammasomes directly recognize these patterns, while others indirectly sense these patterns through changes in the homeostatic environment of the cell. Moreover, although being a normal part of the skin flora, yeasts of the genus Malassezia are associated with several inflammatory skin diseases including pityriasis versicolor (tinea versicolor), atopic eczema, psoriasis, Malassezia folliculitis and onychomycoses. In the context of tolerating fungi during colonization and eliciting, activation, of inflammasomes signaling complexes, has been identified as an integral part of antifungal host defense. While the activation of inflammasomes mainly the NLRP3 one, was shown to be pivotal for innate immunity against pathogenic fungi such as candida albicans, their role in the fungal genus Malassezia remains imprecise. Even though, many observations suggest that simultaneous activation of NLRP3, NLRC4 and AIM2 inflammasomes may play an important role. Conclusions Whereas, chronic inflammasome activation such as by chronic infectious has been tied to the development of metabolic syndromes, neurodegenerative diseases, and cancer progression, a possible interplay between chronic invasion by the genus Malassezia, vigorous immune response to eliminate invading fungal pathogens, disruption of immune sensors of genotoxic stress, development of chronic inflammatory disease and behavioral abnormalities may be a new field of scientific researches. Disclosure of Interest None Declared

Inflammasomes link vascular disease with neuroinflammation and brain disorders

Inflammasomes in neurological disorders — mechanisms and therapeutic potential

Glial Cells and Brain Diseases: Inflammasomes as Relevant Pathological Entities

Role of Inflammasomes in Neuroimmune and Neurodegenerative Diseases: A Systematic Review.

Role of NLRP3 inflammasome in central nervous system diseases

Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders

Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases

Inflammasomes: Mechanisms of Action and Involvement in Human Diseases

Focus on the Role of NLRP3 Inflammasome in Diseases

Inflammasome links traumatic brain injury, chronic traumatic encephalopathy, and Alzheimer's disease

Role of inflammasomes in endothelial dysfunction

The role of inflammation in CNS injury and disease

NLRP3 Inflammasome in Neurological Diseases, from Functions to Therapies

The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology

The NLRP3 inflammasome as a bridge between neuro-inflammation in metabolic and neurodegenerative diseases

Targeting NLRP3 Inflammasome in Translational Treatment of Nervous System Diseases: An Update

Inflammasomes as therapeutic targets in human diseases

From inflammatory signaling to neuronal damage: Exploring NLR inflammasomes in ageing neurological disorders

Inflammasomes: mechanism of action, role in disease, and therapeutics

Role of inflammasomes and neuroinflammation in epilepsy

Chronic activation of inflammasome signaling complexes and enhancement of behavioral abnormalities